Investigational Drug Details
| Drug ID: | D338 |
| Drug Name: | Levofloxacin |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB01137 |
| DrugBank Description: | A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. |
| PubChem ID: | 149096 |
| CasNo: | 100986-85-4 |
| Repositioning for NAFLD: | Yes |
| SMILES: | C[C@H]1COC2=C3N1C=C(C(O)=O)C(=O)C3=CC(F)=C2N1CCN(C)CC1 |
| Structure: |
|
| InChiKey: | GSDSWSVVBLHKDQ-JTQLQIEISA-N |
| Molecular Weight: | 361.3675 |
| DrugBank Targets: | DNA gyrase subunit A; DNA topoisomerase 4 subunit A |
| DrugBank MoA: | Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication and transcription is inhibited. |
| DrugBank Pharmacology: | Levofloxacin, a fluoroquinolone antiinfective, is the optically active L-isomer of ofloxacin. Levofloxacin is used to treat bacterial conjunctivitis, sinusitis, chronic bronchitis, community-acquired pneumonia and pneumonia caused by penicillin-resistant strains of <i>Streptococcus pneumoniae</i>, skin and skin structure infections, complicated urinary tract infections and acute pyelonephritis. |
| DrugBank Indication: | For the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: <i>Corynebacterium</i> species, <i>Staphylococus aureus</i>, <i>Staphylococcus epidermidis</i>, <i>Streptococcus pneumoniae</i>, <i>Streptococcus</i> (Groups C/F/G), Viridans group streptococci, <i>Acinetobacter lwoffii</i>, <i>Haemophilus influenzae</i>, <i>Serratia marcescens</i>. |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L2982 | NCT01195662 | PHASE3 | COMPLETED | YES | 2010-10 | 2016-12-29 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|